Legend Biotech (LEGN) Exchange Rate Effect (2019 - 2025)
Legend Biotech (LEGN) reported Exchange Rate Effect of -$2.7 million for Q4 2025, down 17.39% on a YoY basis from -$3.3 million in Q4 2024, and down 195.17% quarter-over-quarter from $2.8 million in Q3 2025.
Legend Biotech (LEGN) Exchange Rate Effect (2019 - 2025) Analysis & Trends
Legend Biotech has reported Exchange Rate Effect for 7 years, with the latest figure at -$2.7 million in Q4 2025.
- For the quarter ending Q4 2025, Exchange Rate Effect fell 17.39% year-over-year to -$2.7 million; the trailing twelve-month figure through Dec 2025 stood at $6.0 million (up 383.32% YoY), and the FY2025 full-year result was $6.1 million, up 390.48% from the prior year.
- Exchange Rate Effect for Q4 2025 stood at -$2.7 million, down from $2.8 million in the prior quarter.
- The five-year high for Exchange Rate Effect was $4.4 million in Q2 2025, with the low at -$2.7 million in Q4 2025.
- Historically, Exchange Rate Effect has averaged $103700.0 across 5 years, with a median of $9500.0 in 2022.
- Annual changes were most pronounced in 2023 — Exchange Rate Effect slumped 23640.0% — and 2025, when it jumped 49244.44%.
- Legend Biotech's Exchange Rate Effect stood at $78000.0 in 2021, then slumped by 1521.79% to -$1.1 million in 2022, then soared by 231.11% to $1.5 million in 2023, then plunged by 258.18% to -$2.3 million in 2024, then decreased by 17.39% to -$2.7 million in 2025.
- The last three Exchange Rate Effect figures came in at -$2.7 million (Q4 2025), $2.8 million (Q3 2025), and $4.4 million (Q2 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Exchange Rate Effect (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | 3.60 Mn |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | -2.70 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | -40.30 Mn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | 8.68 Mn |
| 10 | Regeneron Pharmaceuticals | 63.43 Bn | 54.67 Bn | 3.31 Bn | -900,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -2.70 Mn |
| Dec 31, 2025 | -2.70 Mn |
| Sep 30, 2025 | 2.84 Mn |
| Sep 30, 2025 | 2.84 Mn |
| Jun 30, 2025 | 4.44 Mn |
| Jun 30, 2025 | 4.44 Mn |
| Mar 31, 2025 | 1.40 Mn |
| Mar 31, 2025 | 1.40 Mn |
| Dec 31, 2024 | -2.30 Mn |
| Dec 31, 2024 | -2.30 Mn |
| Sep 30, 2024 | 524,000.00 |
| Sep 30, 2024 | 524,000.00 |
| Jun 30, 2024 | 9,000.00 |
| Jun 30, 2024 | 9,000.00 |
| Mar 31, 2024 | -343,000.00 |
| Mar 31, 2024 | -343,000.00 |
| Dec 31, 2023 | 1.45 Mn |
| Dec 31, 2023 | 1.45 Mn |
| Sep 30, 2023 | -784,000.00 |
| Sep 30, 2023 | -784,000.00 |